Status:
COMPLETED
Evaluation of Bilateral Internal Iliac Artery Balloon Occlusion in Placenta Accreta Spectrum Management
Lead Sponsor:
Tanta University
Conditions:
Internal Iliac Artery
Balloon Occlusion
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
This study aims to evaluate the efficacy and safety of bilateral internal iliac artery balloon occlusion in the management of the placenta accreta spectrum.
Detailed Description
Placenta accreta spectrum (PAS) is abnormal placental adhesion beyond superficial myometrium, which includes placenta accreta, placenta increta, and placenta percreta. However, there is a desire to p...
Eligibility Criteria
Inclusion
- Age from 18 to 40 years.
- Women with placenta accreta spectrum based on ultrasound (US) and/or magnetic resonance imaging (MRI) findings.
Exclusion
- Women with a bleeding disorder.
- History of known allergy to contrast media.
- Women with Impaired renal function.
- Emergency cesarean section.
- Women had severe attack of bleeding before the operation affecting patient's general condition.
- Women had previous four or more cesarean scars.
- If ultrasound (US) and magnetic resonance imaging (MRI) suspect the presence of placenta accrete preoperative, then intraoperative the placenta is found to have normal adhesion to the uterine wall, this case will be excluded.
Key Trial Info
Start Date :
August 20 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06562712
Start Date
August 20 2024
End Date
December 1 2024
Last Update
June 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tanta University
Tanta, El-Gharbia, Egypt, 31527